Quantcast

Posts related to ‘CTICD’

Rethinking Cell Therapeutics… As An Acquirer? (CTICD)

Cell Therapeutics, Inc. (NASDAQ: CTICD) has long been a controversial stock.  It has brought many rewards for investors and it has also brought much pain to investors.  We recently featured ...
Read Full Story »

BioWatch: Cell Therapeutics Versus FDA, Before ASCO (CTICD)

Cell Therapeutics, Inc. (NASDAQ: CTICD) has been very active since its recent 1-for-6 reverse stock split took place on May 16, 2011.  Its share volume has increased on all but ...
Read Full Story »

The Unusual Suspects, Stocks To Watch This Coming Week (BKS, BRLI, BA, CTICD, LNG, ESRX, NEM, ABX, GG, EWI, LNKD, LULU, MCP, PT, RYAAY, STEC, YHOO)

Each weekend we review the issues of the week before and look to the calendar ahead to see which issues are going to stand out with news or events.  We ...
Read Full Story »